Inmunoterapia por tipo de cáncer Inmunoterapia: Para todos los tipos de cáncer Immunotherapy is a form of cancer treatment that uses the power of the body’s immune system to prevent, control, and eliminate cancer. From the preventive vaccine for cervical and liver cancer to the first therapy ever proven to extend the lives of patients with metastatic melanoma, immunology has already led to major treatment breakthroughs for a number of cancers. Every cancer type is unique, though, and immunology and immunotherapy are impacting each cancer in different ways. Explore immunotherapies by cancer type and explore different kinds of treatment, why immunotherapy matters, and how to support cancer immunotherapy research. Cáncer de vejiga The first FDA-approved immunotherapy treatment—Bacillus Calmette-Guérin cancer vaccine—was for bladder cancer in 1990. Cáncer de cerebro Cancers of the brain and nervous system are relatively rare but very serious. Immunotherapy is showing significant promise where… Cáncer de mama New studies of immunotherapy in the treatment of breast cancer, one of the most commonly diagnosed cancer types among… Cáncer de cuello uterino Three preventive cancer vaccines are already helping to stop cervical cancer, and many new immunotherapeutic approaches are in clinical… Cáncer infantil Immunotherapy offers a potential way to treat childhood (pediatric) cancer without the damaging, long-term side effects of conventional treatments. Cáncer colorrectal There are several FDA-approved immunotherapies for colorectal cancer, for which patients are in urgent need of new treatment options…. Cáncer de esófago Immunotherapy for esophageal cancer is being explored to reduce recurrence, as a first-line treatment, and in novel combinations for… Cáncer de cabeza y cuello Immunotherapy offers exciting new treatment options for patients with cancers of the mouth, throat, voice box, sinuses, nose, and… Cáncer renal Immunotherapy for kidney cancer—also called renal cell cancer—has tremendously changed the treatment landscape and overall survival of patients with… Leucemia There are several FDA-approved immunotherapies for leukemia (leukaemia) and ongoing research demonstrates even greater potential for new treatments. Cáncer de hígado In addition to the first FDA-approved hepatitis B preventive cancer vaccine, immunotherapy treatments can enhance the immune system’s response… Cáncer de pulmón Immunotherapy is a promising treatment option for advanced lung cancer, alone or in combination with conventional treatments like chemotherapy… Linfoma Several FDA-approved immunotherapies offer treatment options to children and adults with Hodgkin and non-Hodgkin lymphoma. Melanoma Immunotherapy has changed the way melanoma is treated. In particular, checkpoint inhibitors are responsible for the increasing survival rate… Mieloma múltiple Immunotherapy for multiple myeloma is a promising new treatment option, with the potential to result in long-term cancer remission… Cáncer de ovario Research into immunotherapy for ovarian cancer is promising, especially since more treatment options for patients and oncologists are urgently… Cáncer de páncreas Pancreatic cancer has few treatment options, so pancreatic cancer immunotherapy research is vital to providing patients with new hope. Cáncer de próstata With a cancer vaccine and checkpoint inhibitor already approved, immunotherapy research offers new hope to patients with advanced prostate… Sarcoma Immunotherapy for sarcoma has some success cases, including the earliest known instances of spontaneous regression, although sarcoma cancer immunology… Cáncer de piel Skin cancers are common, often diagnosed at an early stage, and among the first cancers to respond to immunotherapy. Cáncer de estómago Immunotherapies, including checkpoint inhibitors and targeted antibodies, offer promising new treatment options for stomach (gastric) cancer patients. Cáncer de útero Immunotherapy for uterine (endometrial) cancer is an emerging area of research and treatment, especially for patients with advanced cases….
Cáncer de vejiga The first FDA-approved immunotherapy treatment—Bacillus Calmette-Guérin cancer vaccine—was for bladder cancer in 1990.
Cáncer de cerebro Cancers of the brain and nervous system are relatively rare but very serious. Immunotherapy is showing significant promise where…
Cáncer de mama New studies of immunotherapy in the treatment of breast cancer, one of the most commonly diagnosed cancer types among…
Cáncer de cuello uterino Three preventive cancer vaccines are already helping to stop cervical cancer, and many new immunotherapeutic approaches are in clinical…
Cáncer infantil Immunotherapy offers a potential way to treat childhood (pediatric) cancer without the damaging, long-term side effects of conventional treatments.
Cáncer colorrectal There are several FDA-approved immunotherapies for colorectal cancer, for which patients are in urgent need of new treatment options….
Cáncer de esófago Immunotherapy for esophageal cancer is being explored to reduce recurrence, as a first-line treatment, and in novel combinations for…
Cáncer de cabeza y cuello Immunotherapy offers exciting new treatment options for patients with cancers of the mouth, throat, voice box, sinuses, nose, and…
Cáncer renal Immunotherapy for kidney cancer—also called renal cell cancer—has tremendously changed the treatment landscape and overall survival of patients with…
Leucemia There are several FDA-approved immunotherapies for leukemia (leukaemia) and ongoing research demonstrates even greater potential for new treatments.
Cáncer de hígado In addition to the first FDA-approved hepatitis B preventive cancer vaccine, immunotherapy treatments can enhance the immune system’s response…
Cáncer de pulmón Immunotherapy is a promising treatment option for advanced lung cancer, alone or in combination with conventional treatments like chemotherapy…
Linfoma Several FDA-approved immunotherapies offer treatment options to children and adults with Hodgkin and non-Hodgkin lymphoma.
Melanoma Immunotherapy has changed the way melanoma is treated. In particular, checkpoint inhibitors are responsible for the increasing survival rate…
Mieloma múltiple Immunotherapy for multiple myeloma is a promising new treatment option, with the potential to result in long-term cancer remission…
Cáncer de ovario Research into immunotherapy for ovarian cancer is promising, especially since more treatment options for patients and oncologists are urgently…
Cáncer de páncreas Pancreatic cancer has few treatment options, so pancreatic cancer immunotherapy research is vital to providing patients with new hope.
Cáncer de próstata With a cancer vaccine and checkpoint inhibitor already approved, immunotherapy research offers new hope to patients with advanced prostate…
Sarcoma Immunotherapy for sarcoma has some success cases, including the earliest known instances of spontaneous regression, although sarcoma cancer immunology…
Cáncer de piel Skin cancers are common, often diagnosed at an early stage, and among the first cancers to respond to immunotherapy.
Cáncer de estómago Immunotherapies, including checkpoint inhibitors and targeted antibodies, offer promising new treatment options for stomach (gastric) cancer patients.
Cáncer de útero Immunotherapy for uterine (endometrial) cancer is an emerging area of research and treatment, especially for patients with advanced cases….
